LeukoTreat aims at developing therapeutic strategies for leukodystrophy (LD) affected patients

Intranet Print the page
Therapeutic strategies for leukodystrophy affected patients - LEUKOTREAT (Home)
Flux RSS des actualités News

04/12/2013

Updated Website

LeukoTreat was completed on August 31st, 2013. The Project website has ...

04/12/2013

Documents to download

All documents prepared by the Ethics Research Group during LeukoTreat ...
See all news

Newsletter

Please enter your e-mail address

Last update : 04/12/2013

Presentation of LeukoTreat

LeukoTreat was a European project funded by the European Commission under the 7th Framework Programme for Research and Development. Gathering 24 partners, the project began on March 1st, 2010 and ended on August 31st, 2013. With the aim of developing therapeutic strategies for the largest number of leukodystrophy (LD) affected patients as well as developing further applications to more common white matter disorders and neurodegenerative diseases, five research axes were pursued during LeukoTreat:

  • The design and development of the LeukoDataBase (LeukoDB)
  • Biomarkers for leukodystrophies treatment
  • Pharmacological strategies to treat leukodystrophies
  • Gene and cell therapies in leukodystrophies
  • Ethics, notably in relation to the LeukoDB

 

Hereafter, main documents stemming from LeukoTreat can be downloaded:

LeukoTreat Partners - Kick-off Meeting